APA (7th ed.) Citation

Ozaka, M., Ishii, H., Sato, T., Ueno, M., Ikeda, M., Uesugi, K., . . . Furuse, J. (2018). A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. Cancer chemotherapy and pharmacology, 81(6), 1017-1023. https://doi.org/10.1007/s00280-018-3577-9

Chicago Style (17th ed.) Citation

Ozaka, Masato, et al. "A Phase II Study of Modified FOLFIRINOX for Chemotherapy-naïve Patients with Metastatic Pancreatic Cancer." Cancer Chemotherapy and Pharmacology 81, no. 6 (2018): 1017-1023. https://doi.org/10.1007/s00280-018-3577-9.

MLA (9th ed.) Citation

Ozaka, Masato, et al. "A Phase II Study of Modified FOLFIRINOX for Chemotherapy-naïve Patients with Metastatic Pancreatic Cancer." Cancer Chemotherapy and Pharmacology, vol. 81, no. 6, 2018, pp. 1017-1023, https://doi.org/10.1007/s00280-018-3577-9.